Gentian Diagnostics ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	176.5	152.07	135.15	101.64	83.12
Other Revenue	-	-	-	10.29	16.89
Revenue	176.5	152.07	135.15	111.92	100.01
Revenue Growth (YoY)	16.06%	12.52%	20.76%	11.91%	26.78%
Cost of Revenue	78.3	69.25	70.91	52.64	43.18
Gross Profit	98.2	82.82	64.25	59.29	56.83
Selling, General & Admin	54.33	49.78	48.12	37.42	34.35
Research & Development	23.16	21.92	36.08	-	-
Other Operating Expenses	-4.75	-4.6	-7.19	34.86	37.98
Operating Expenses	72.75	67.09	77.01	82.52	79.68
Operating Income	25.45	15.72	-12.76	-23.23	-22.85
Interest Expense	-5.22	-0.66	-0.8	-1.26	-1.38
Interest & Investment Income	5.43	3.59	2.67	1.11	0.09
Currency Exchange Gain (Loss)	-	1.5	0.6	-0.2	-0.6
Other Non Operating Income (Expenses)	-	-0.08	-0.08	-0.05	-0.06
EBT Excluding Unusual Items	25.67	20.06	-10.37	-23.62	-24.79
Pretax Income	25.67	20.06	-10.37	-23.62	-24.79
Income Tax Expense	12.41	-25.23	0.28	-	-
Net Income	13.26	45.29	-10.65	-23.62	-24.79
Net Income to Common	13.26	45.29	-10.65	-23.62	-24.79
Net Income Growth	-70.73%	-	-	-	-
Shares Outstanding (Basic)	15	15	15	15	15
Shares Outstanding (Diluted)	15	16	15	15	15
Shares Change (YoY)	-1.73%	2.21%	-	0.04%	0.07%
EPS (Basic)	0.86	2.94	-0.69	-1.53	-1.61
EPS (Diluted)	0.86	2.87	-0.69	-1.53	-1.61
EPS Growth	-70.05%	-	-	-	-
Free Cash Flow	41.38	12.08	14.5	-22.59	-28.08
Free Cash Flow Per Share	2.67	0.77	0.94	-1.47	-1.82
Dividend Per Share	0.600	0.400	-	-	-
Dividend Growth	50.00%	-	-	-	-
Gross Margin	55.64%	54.46%	47.54%	52.97%	56.83%
Operating Margin	14.42%	10.34%	-9.44%	-20.76%	-22.84%
Profit Margin	7.51%	29.79%	-7.88%	-21.10%	-24.79%
Free Cash Flow Margin	23.45%	7.94%	10.73%	-20.18%	-28.07%
EBITDA	34.57	18.6	-9.9	-20.49	-21.32
EBITDA Margin	19.58%	12.23%	-7.32%	-18.30%	-21.32%
D&A For EBITDA	9.12	2.88	2.87	2.75	1.53
EBIT	25.45	15.72	-12.76	-23.23	-22.85
EBIT Margin	14.42%	10.34%	-9.44%	-20.76%	-22.84%
Effective Tax Rate	48.35%	-	-	-	-
Revenue as Reported	-	-	-	111.92	100.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.